TAUG — Tauriga Sciences Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.44m
- $0.29m
Annual balance sheet for Tauriga Sciences, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
C2017 March 31st | 2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-Q | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.001 | 0.645 | 0.809 | 0.285 | 1.61 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | 0.001 | — | 0.043 | 0.032 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.003 | 0.686 | 0.948 | 0.608 | 2.4 |
| Net Property, Plant And Equipment | 0.001 | 0.002 | 0.013 | 0.036 | 0.081 |
| Other Long Term Assets | |||||
| Total Assets | 0.004 | 0.689 | 0.961 | 0.643 | 2.49 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.02 | 0.319 | 0.457 | 0.943 | 1.17 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.09 | 0.391 | 0.457 | 0.952 | 1.22 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -2.09 | 0.297 | 0.503 | -0.308 | 1.27 |
| Total Liabilities & Shareholders' Equity | 0.004 | 0.689 | 0.961 | 0.643 | 2.49 |
| Total Common Shares Outstanding |